Relief Therapeutics Holding Stock Investor Sentiment

RLFTF Stock  USD 3.45  0.15  4.17%   
Roughly 62% of Relief Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Relief Therapeutics Holding suggests that many traders are alarmed regarding Relief Therapeutics' prospects. The current market sentiment, together with Relief Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Relief Therapeutics stock news signals to limit their universe of possible portfolio assets.
Relief Therapeutics otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Relief daily returns and investor perception about the current price of Relief Therapeutics Holding as well as its diversification or hedging effects on your existing portfolios.
  
3 days ago at news.google.com         
Relief Reports Half-Year 2021 Results and Provides Corporate Update - ACCESS Newswire
Google News at Macroaxis
over two weeks ago at news.google.com         
Relief Therapeutics to get European patent for investigational drug RLFTD011 - MSN
Google News at Macroaxis
over two weeks ago at news.google.com         
Relief Therapeutics to get European patent for investigational drug RLFTD011 - Seeking Alpha
Google News at Macroaxis
over two weeks ago at news.google.com         
Major Patent Win Reliefs Rare Disease Treatment Locks 17-Year EU Protection - StockTitan
Google News at Macroaxis
over two months ago at news.google.com         
Relief Therapeutics Provides Update on Potential Transaction with Renexxion - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
TNXP - Tonix Pharmaceuticals Holding Corp. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger - Yahoo Fin...
Google News at Macroaxis
over three months ago at news.google.com         
We Think Relief Therapeutics Holding Can Easily Afford To Drive Business Growth - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics stock gains on trial data - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermol...
Google News at Macroaxis
over three months ago at news.google.com         
Relief stock gains on data rivaling BioMarin - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Holding SAs Share Price Boosted 52 percent But Its Business Prospects Need A Lif...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Holding SAs Share Price Boosted 52 percent But Its Business Prospects Need A Lif...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Holding SA Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 - Marke...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Secures up to 11 Million from Royalty Sales - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Relief Therapeutics that are available to investors today. That information is available publicly through Relief media outlets and privately through word of mouth or via Relief internal channels. However, regardless of the origin, that massive amount of Relief data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Relief Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Relief Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Relief Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Relief Therapeutics alpha.

Relief Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Relief OTC Stock analysis

When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments